Esperion Therapeutics | ESPR - Trade Debtors

Stock Price
3.49
Daily Change
0.10 2.80%
Monthly
-1.83%
Yearly
85.37%
Q1 Forecast
2.70

Esperion Therapeutics reported $60.36M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Alterity Therapeutics Limited AUD 8.67M 1.59M Jun/2023
Amarin USD 127.31M 8.18M Sep/2025
Amgen USD 9.57B 1.08B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Cipla INR 74.61B 19.39B Sep/2025
CSL USD 2.97B 638M Jun/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Geron USD 39.36M 5.38M Jun/2025
Grifols EUR 1.29B 83.03M Sep/2025
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 1.05B 589M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024